{
}
UBS has maintained a "Buy" rating for Infineon, setting a target price of 41 euros. Analyst Francois-Xavier Bouvignies noted that customer inventories are nearing healthier levels and pricing remains stable, with Infineon alongside Texas Instruments and Renesas Electronics as preferred stocks in the semiconductor sector.
UBS AG London Branch is set to stabilize the market for SIX Finance (Luxembourg) S.A.'s EUR 500 million senior unsecured bonds, guaranteed by SIX Group AG, starting today and potentially lasting until June 27, 2025. The stabilization measures, compliant with EU regulations, aim to maintain the bond's market price but may be discontinued at any time. The offer details remain unconfirmed, and the securities are not registered in the U.S., prohibiting public offerings there.
UBS has maintained a "Neutral" rating for Freenet, setting a target price of 33 euros. The mobile phone provider fell short of expectations in several areas, leading analyst Polo Tang to predict a potential decline in shares following a recent strong performance.
The recent downgrade of the US's AAA rating by Moody's has heightened concerns over the USD, prompting investors to consider rebalancing their FX exposure. With expected gradual USD weakness, opportunities to diversify into currencies like EUR, JPY, GBP, and AUD are emerging, alongside maintaining a 5% gold allocation due to ongoing geopolitical tensions. Additionally, the AUD faces downside risks from a dovish RBA, while the USDHKD remains a viable funding currency within its pegged trading band, particularly when interest rate differentials favor HKD borrowing.
UBS has upgraded its price target for Schott Pharma from €28.20 to €29.20 while maintaining a "buy" rating. The pharmaceutical supplier reported a strong quarter, although a cautious outlook for 2025 has tempered expectations, according to analyst Olivier Calvet.
UBS has increased its price target for GEA Group from €59 to €67 while maintaining a "Buy" rating. Analyst Sven Weier cited better-than-expected first-quarter results and raised order estimates for 2025 and 2026, surpassing consensus expectations, driven by strong order momentum.
UBS has increased its price target for Gea Group from 59 to 67 euros while maintaining a "Buy" rating. Analyst Sven Weier cited better-than-expected first-quarter results and raised order estimates for 2025 and 2026, surpassing consensus expectations, with order momentum being a key factor in this optimistic outlook.
UBS has maintained a buy recommendation for GEA, raising its price target from €59 to €67, indicating a potential upside of 17%. The company anticipates organic sales growth of over 5% annually until 2030, with EBITDA growth projected between 17% and 19%, and a return on capital employed exceeding 45%.
In a recent podcast, financial journalists discussed a record DAX performance, overpriced whiskey, and Ryanair's rally, alongside insights on major companies like Volkswagen, Mercedes, and Lufthansa. They highlighted the positive quarterly results from over 60% of DAX companies and upcoming Annual General Meetings for firms such as Symrise and Porsche. The conversation also touched on various market trends and investment risks, emphasizing the volatility of stocks and leveraged products.
Barclays has upgraded Aedifica to 'overweight' from 'underweight', supporting its return to a growth strategy. The brokerage raised its 5-year EPS growth forecast to 0.9% and increased the price target by 23% to EUR 74, citing potential benefits from a merger with Cofinimmo. Out of 15 analysts, nine recommend the stock as a "strong buy" or "buy."
Euro
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS Maintains Buy Rating for Infineon with Target Price of 41 Euros
10:09 22.05.2025
UBS Initiates Stabilization for SIX Finance Bond Issue Ahead of Maturity
09:37 22.05.2025
UBS Maintains Neutral Rating for Freenet with Target Price of 33 Euros
09:33 22.05.2025
USD Volatility Prompts Strategic FX Rebalancing Amid Economic Uncertainty
Australian Dollar
Euro
British Pound Sterling
United States Dollar
Japanese Yen
JPN
AUS
HKG
USA
DEU
Julian Weeks
Show more
02:30 22.05.2025
UBS raises Schott Pharma price target to 29.20 euros maintains buy rating
13:54 20.05.2025
ubs raises gea group price target to 67 euros maintains buy rating
13:50 20.05.2025
ubs raises gea group price target to 67 euros maintains buy rating
12:37 20.05.2025
ubs raises price target for gea amid positive growth outlook
11:01 20.05.2025
financial insights on market trends and corporate developments in germany
Euro
Rheinmetall AG
Rivian Automotive Inc.
Nvidia Corporation
Regeneron Pharmaceuticals Inc.
Salzgitter AG
VOLKSWAGEN AG
Xiaomi Corporation
Ferrari N.V.
Renk AG
Mercedes-Benz AG
KOR
DEU
Christoph Kapalschinski
Nando Sommerfeldt
Donald Trump
Show more
09:08 20.05.2025
Barclays upgrades Aedifica to overweight citing growth strategy and acquisitions
08:41 20.05.2025
Trending
Subcategory
Countries:
Companies:
Currencies:
People: